Abstract:The cannabinoid receptor 2 (CB2) plays an important role in the immune system. Although a few of GPCRs crystallographic structures have been reported, it is still challenging to obtain functional transmembrane proteins and high resolution X-ray crystal structures, such as for the CB2 receptor. In the present work, we used 10 reported crystal structures of GPCRs which had high sequence identities with CB2 to construct homology-based comparative CB2 models. We applied these 10 models to perform a prescreen by using a training set consisting of 20 CB2 active compounds and 980 compounds randomly selected from the National Cancer Institute (NCI) database. We then utilized the known 170 cannabinoid receptor 1 (CB1) or CB2 selective compounds for further validation. Based on the docking results, we selected one CB2 model (constructed by β1AR) that was most consistent with the known experimental data, revealing that the defined binding pocket in our CB2 model was well-correlated with the training and testing data studies. Importantly, we identified a potential allosteric binding pocket adjacent to the orthosteric ligand-binding site, which is similar to the reported allosteric pocket for sodium ion Na(+) in the A2AAR and the δ-opioid receptor. Our studies in correlation of our data with others suggested that sodium may reduce the binding affinities of endogenous agonists or its analogs to CB2. We performed a series of docking studies to compare the important residues in the binding pockets of CB2 with CB1, including antagonist, agonist, and our CB2 neutral compound (neutral antagonist) XIE35-1001. Then, we carried out 50 ns molecular dynamics (MD) simulations for the CB2 docked with SR144528 and CP55940, respectively. We found that the conformational changes of CB2 upon antagonist/agonist binding were congruent with recent reports of those for other GPCRs. Based on these results, we further examined one known residue, Val113(3.32), and predicted two new residues, Phe183 in ECL2 and Phe281(7.35), that were important for SR144528 and CP55940 binding to CB2. We then performed site-directed mutation experimental study for these residues and validated the predictions by radiometric binding affinity assay.

Crystal Structure of A Mycobacterial Insig Homolog Provides Insight into How These Sensors Monitor Sterol Levels

Structural Basis for Sterol Sensing by Scap and Insig

A structure of human Scap bound to Insig-2 suggests how their interaction is regulated by sterols

Molecular determinant of sterol recognition by sterol cleavage activatory protein

Crystal Structure of Tabtoxin Resistance Protein Complexed with Acetyl Coenzyme A

Structure of Human Stabilin-1 Interacting Chitinase-like Protein (SI-CLP) Reveals a Saccharide-binding Cleft with Lower Sugar-binding Selectivity*

Crystal Structure and Acetylation of BioQ Suggests a Novel Regulatory Switch for Biotin Biosynthesis in Mycobacterium Smegmatis

Structural Insights into Immunoglobulin M

Crystal structure of the Rib domain of the cell-wall-anchored surface protein from Limosilactobacillus reuteri

Structural Insights into a Shared Mechanism of Human STING Activation by a Potent Agonist and an Autoimmune Disease-Associated Mutation.

The Structural Basis for the Sensing and Binding of Cyclic Di-Gmp by STING.

1.42 Å crystal structure of mini-IGF-1(2): an analysis of the disulfide isomerization property and receptor binding property of IGF-1 based on the three-dimensional structure

Molecular basis for the role of disulfide-linked αCTs in the activation of insulin-like growth factor 1 receptor and insulin receptor

Comprehensive computational investigation for ligand recognition and binding dynamics of SdiA: a degenerate LuxR -type receptor in Klebsiella pneumoniae

Insight into binding of endogenous neurosteroid ligands to the sigma-1 receptor

Crystal structure of methyltransferase CbiL from Akkermansia muciniphila

Structural Insights into Secretory Immunoglobulin A and Its Interaction with a Pneumococcal Adhesin

Modeling, Molecular Dynamics Simulation, and Mutation Validation for Structure of Cannabinoid Receptor 2 Based on Known Crystal Structures of GPCRs

Insulin-induced conformational changes in the full-length insulin receptor: structural insights gained from molecular modeling analyses

Functional Characterization and Crystal Structure of the Type II Peptidyl Carrier Protein ColA1a in Collismycins Biosynthesis†

Cryo-EM Structure Reveals Polymorphic Ligand-bound States of IGF1R